Home
Clinical Resources Search
PQI: Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

Download PQI pdf 0.19MB

Last Updated: September 27, 2023

By: Renee Shirakawa Kwock, PharmD, BCOP

About this PQI

The purpose of this PQI is to provide an outline on obinutuzumab and to provide guidance on clinical considerations for its optimal medication management.

More About This PQI

PQI:

Ibrutinib-Imbruvica-Expansion-with-Obinutuzumab-Gazyva_PQI_NCODA pdf 0.18MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Chronic Lymphocityic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Follicular Lymphoma (FL) Gazyva Obinutuzumab

PQI

Frequently Searched

Supported by

Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

About this PQI

More About This PQI

PQI:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

S9 E3: Firefighter Health & Cancer Prevention

S9 E2: Love Languages in Cancer Care

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

S8 Bonus Eps 2: Inside ASCO 2025

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia

PQI: Patient Screening for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI: Tazemetostat (Tazverik®) Management in Relapsed/Refractory Follicular Lymphoma

PQI: Initiating Mosunetuzumab-axgb (Lunsumio) in Relapsed/Refractory Follicular Lymphoma

PQI: Duvelisib (Copiktra®) for Chronic Lymphocytic Leukemia

PQI: Ibrutinib (Imbruvica®) Expansion with Obinutuzumab (Gazyva®)

PQI: Ibrutinib (Imbruvica®) Expansion with Obinutuzumab (Gazyva®)

S9 E3: Firefighter Health & Cancer Prevention

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E2: Love Languages in Cancer Care